UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Jessica Coblentz, Dust in Blood: A Theology of Life with Depression

Journal of moral theology, 2023-01, Vol.12 (1)

Staron, Andrew

2023

Volltextzugriff (PDF)

Marked progress in AL amyloidosis survival: a 40-year longitudinal natural history study

Blood cancer journal (New York), 2021-08, Vol.11 (8), p.139-139, Article 139

2021

Volltextzugriff (PDF)

Differences in the cytogenetic underpinnings of AL amyloidosis among African Americans and Caucasian Americans

Blood cancer journal (New York), 2022-07, Vol.12 (7), p.100-4, Article 100

2022

Volltextzugriff (PDF)

Light chain amyloidosis associated with Waldenström macroglobulinemia: treatment and survival outcomes

Haematologica (Roma), 2023-06, Vol.108 (6), p.1680-1684

2023

Volltextzugriff (PDF)

Non-producer multiple myeloma presenting with acute hyperammonemic encephalopathy: case report

Diagnostic pathology, 2023-01, Vol.18 (1), p.1-1, Article 1

2023

Volltextzugriff (PDF)

Augustine on Memory. By KevinGrove. Oxford: Oxford University Press, 2021. Pp. x, 265. £64.00

Heythrop journal, 2023-05, Vol.64 (3), p.444-446

Staron, Andrew

2023

Volltextzugriff (PDF)

Prevalence of plasma cell and lymphoproliferative disorders among blood relatives of patients with light chain amyloidosis

British journal of haematology, 2022-09, Vol.198 (5), p.861-865

2022

Volltextzugriff (PDF)

Longitudinal Assessment and Prognostic Importance of Minimal Residual Disease (MRD) By Multiparametric Flow Cytometry in Patients with Systemic Light Chain (AL) Amyloidosis

Blood, 2021-11, Vol.138 (Supplement 1), p.3767-3767

2021

Volltextzugriff (PDF)

Factors Underlying Impaired Organ Recovery Despite a Deep Hematologic Response in Patients with Systemic AL Amyloidosis

Blood, 2023-11, Vol.142 (Supplement 1), p.3410-3410

2023

Volltextzugriff (PDF)

Systemic AL Amyloidosis in Patients Younger Than 40 Years of Age: Clinical Presentation and Outcomes

Blood, 2023-11, Vol.142 (Supplement 1), p.6762-6762

2023

Volltextzugriff (PDF)

Prospective Evaluation of Measurable Residual Disease (MRD) and Sustainability of the Response in Patients with Systemic AL Amyloidosis Treated with Daratumumab

Blood, 2023-11, Vol.142 (Supplement 1), p.3405-3405

2023

Volltextzugriff (PDF)

Centered Toward the Margins in advance: Teaching Pope Francis’s Revolution of Mercy

Praxis (Charlottesville, Va.), 2019

Staron, Andrew

2019

Volltextzugriff (PDF)

Centered Toward the Margins: Teaching Pope Francis’s Revolution of Mercy

Praxis (Charlottesville, Va.), 2018, Vol.1 (2), p.142-155

Staron, Andrew

2018

Volltextzugriff (PDF)

Orthotopic heart transplant rejection in association with immunomodulatory therapy for AL amyloidosis: A case series and review of the literature

American journal of transplantation, 2019-11, Vol.19 (11), p.3185-3190

2019

Volltextzugriff (PDF)

A 40-Year Natural History Study of Overall Survival and Primary Causes of Death in Systemic Light Chain (AL) Amyloidosis

Blood, 2021-11, Vol.138 (Supplement 1), p.155-155

2021

Volltextzugriff (PDF)

Systemic AL Amyloidosis in Patients Younger Than 40 Years of Age: Clinical Presentation and Outcomes

Clinical lymphoma, myeloma and leukemia, 2024-08

2024

Volltextzugriff (PDF)

Abnormal Global Longitudinal Strain Correlates with Amyloidogenic Light Chain-Induced Cardiac Dysfunction via Direct Myocardial Toxicity in Patients without Significant Amyloid Fibril Deposition

Blood, 2023-11, Vol.142 (Supplement 1), p.3415-3415

2023

Volltextzugriff (PDF)

When a Number Is Just a Number: Duffy-Null Blood Group Phenotype, Absolute Neutrophil Count, and Incidence of Neutropenic Fever and Chemotherapy Dose Reductions in Patients Treated for Plasma Cell Dyscrasias

Blood, 2023-11, Vol.142 (Supplement 1), p.7432-7432

2023

Volltextzugriff (PDF)

Racial and Ethnic Disparities in Systemic AL Amyloidosis: Examining Differences in Clinical Presentation and Outcomes

Blood, 2020-11, Vol.136 (Supplement 1), p.51-51

2020

Volltextzugriff (PDF)

Long‐term outcomes of renal AL amyloidosis patients undergoing autologous stem cell transplantation: Validating the performance of the renal staging system

American journal of hematology, 2024-08

2024

Volltextzugriff (PDF)

Factors affecting the accuracy of amyloidosis identification and referral to a specialty centre

Amyloid, 2023-07, Vol.ahead-of-print (ahead-of-print), p.1-6

2023

Volltextzugriff (PDF)

Successful dasatinib therapy in newly diagnosed chronic myeloid leukemia in the setting of short bowel syndrome

Journal of oncology pharmacy practice, 2023-09, Vol.29 (6), p.1489-1493

2023

Volltextzugriff (PDF)

The Changing Face of Amyloidosis Referrals at a Tertiary Center over the Past 3 Decades

Blood, 2018-11, Vol.132 (Supplement 1), p.5536-5536

2018

Volltextzugriff (PDF)

Race/ethnicity in systemic AL amyloidosis: perspectives on disease and outcome disparities

Blood cancer journal (New York), 2020-11, Vol.10 (11), p.118-118, Article 118

2020

Volltextzugriff (PDF)

Systemic AL amyloidosis with an undetectable plasma cell dyscrasia: A zebra without stripes

American journal of hematology, 2020-02, Vol.95 (2), p.E45-E48

2020

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(33)

Publikationsform

Sprache

Englisch
(47)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(24)
Life Sciences & Biomedicine
(19)
Humans
(12)
Amyloidosis
(11)
Hematology
(9)
Male
(9)
Female
(6)
Middle Aged
(6)
Technology
(6)
Al Amyloidosis
(5)
Oncology
(5)
Physical Sciences
(5)
Adult
(4)
Materials Science
(4)
Materials Science, Multidisciplinary
(4)
Physics
(4)
Physics, Applied
(4)
Aged
(3)
Biochemistry & Molecular Biology
(3)
Immunoglobulin Light-Chain Amyloidosis - Diagnosis
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Jessica Coblentz, Dust in Blood: A Theology of Life with Depression

Marked progress in AL amyloidosis survival: a 40-year longitudinal natural history study

Differences in the cytogenetic underpinnings of AL amyloidosis among African Americans and Caucasian Americans

Light chain amyloidosis associated with Waldenström macroglobulinemia: treatment and survival outcomes

Non-producer multiple myeloma presenting with acute hyperammonemic encephalopathy: case report

Augustine on Memory. By KevinGrove. Oxford: Oxford University Press, 2021. Pp. x, 265. £64.00

Prevalence of plasma cell and lymphoproliferative disorders among blood relatives of patients with light chain amyloidosis

Longitudinal Assessment and Prognostic Importance of Minimal Residual Disease (MRD) By Multiparametric Flow Cytometry in Patients with Systemic Light Chain (AL) Amyloidosis

Factors Underlying Impaired Organ Recovery Despite a Deep Hematologic Response in Patients with Systemic AL Amyloidosis

Systemic AL Amyloidosis in Patients Younger Than 40 Years of Age: Clinical Presentation and Outcomes

Prospective Evaluation of Measurable Residual Disease (MRD) and Sustainability of the Response in Patients with Systemic AL Amyloidosis Treated with Daratumumab

Centered Toward the Margins in advance: Teaching Pope Francis’s Revolution of Mercy

Centered Toward the Margins: Teaching Pope Francis’s Revolution of Mercy

Orthotopic heart transplant rejection in association with immunomodulatory therapy for AL amyloidosis: A case series and review of the literature

A 40-Year Natural History Study of Overall Survival and Primary Causes of Death in Systemic Light Chain (AL) Amyloidosis

Systemic AL Amyloidosis in Patients Younger Than 40 Years of Age: Clinical Presentation and Outcomes

Abnormal Global Longitudinal Strain Correlates with Amyloidogenic Light Chain-Induced Cardiac Dysfunction via Direct Myocardial Toxicity in Patients without Significant Amyloid Fibril Deposition

When a Number Is Just a Number: Duffy-Null Blood Group Phenotype, Absolute Neutrophil Count, and Incidence of Neutropenic Fever and Chemotherapy Dose Reductions in Patients Treated for Plasma Cell Dyscrasias

Racial and Ethnic Disparities in Systemic AL Amyloidosis: Examining Differences in Clinical Presentation and Outcomes

Long‐term outcomes of renal AL amyloidosis patients undergoing autologous stem cell transplantation: Validating the performance of the renal staging system

Factors affecting the accuracy of amyloidosis identification and referral to a specialty centre

Successful dasatinib therapy in newly diagnosed chronic myeloid leukemia in the setting of short bowel syndrome

The Changing Face of Amyloidosis Referrals at a Tertiary Center over the Past 3 Decades

Race/ethnicity in systemic AL amyloidosis: perspectives on disease and outcome disparities

Systemic AL amyloidosis with an undetectable plasma cell dyscrasia: A zebra without stripes

Suchergebnisse filtern